Related Experiment Video

Updated: Jul 9, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular

Peter J Francis1, Dennis W Schultz, Sara Hamon

  • 1Macular Degeneration Center, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States of America. francisp@ohsu.edu

Plos One
|November 29, 2007
PubMed

Insights

The complement factor H (CFH) gene is linked to both early and advanced age-related macular degeneration (AMD). Specific CFH gene variations and haplotypes significantly increase susceptibility to AMD, including drusen formation.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss in individuals over 50.
  • The complement factor H (CFH) gene is a known risk factor for advanced AMD.
  • The role of CFH in earlier AMD stages requires further investigation.

Purpose of the Study:

  • To elucidate the functional role of the CFH gene in the AMD disease process.
  • To determine if CFH is associated with early or intermediate forms of AMD.
  • To identify specific CFH gene polymorphisms and haplotypes linked to AMD susceptibility.

Main Methods:

  • Genotyping of single nucleotide polymorphisms (SNPs) at the CFH gene locus in three distinct AMD populations.
  • Analysis of polymorphisms and haplotypes within and around the CFH gene.
  • Statistical association testing to evaluate the role of CFH variants in AMD.

Main Results:

  • The CFH gene is associated with both early/intermediate and advanced AMD across familial and sporadic cases.
  • The CFH SNP rs2274700 showed the strongest association with AMD in the studied populations.
  • A haplotype combining rs2274700, Y402H SNP, and rs1061147 demonstrated the most significant association with AMD (p<10(-9)).

Conclusions:

  • The CFH gene is implicated in the development of drusen and advanced AMD.
  • Novel susceptibility and protective haplotypes within the CFH gene were identified in AMD patients.
  • These findings, replicated across diverse AMD populations, reinforce CFH's critical role in AMD pathogenesis.
Abstract

More Related Videos

Enrichment of Bruch's Membrane from Human Donor Eyes10:22

Enrichment of Bruch's Membrane from Human Donor Eyes

Published on: November 15, 2015

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Genetic Lingo01:11

Genetic Lingo

Overview
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...